X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (10378) 10378
Newsletter (293) 293
Newspaper Article (60) 60
Book Chapter (21) 21
Transcript (14) 14
Report (8) 8
Book / eBook (7) 7
Conference Proceeding (5) 5
Magazine Article (5) 5
Dissertation (4) 4
Book Review (1) 1
Publication (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (7606) 7606
anthracyclines (7360) 7360
cancer (5269) 5269
female (5167) 5167
chemotherapy (4950) 4950
oncology (4467) 4467
doxorubicin (3473) 3473
middle aged (3038) 3038
adult (2702) 2702
antineoplastic combined chemotherapy protocols - therapeutic use (2634) 2634
male (2575) 2575
aged (2512) 2512
breast cancer (2447) 2447
breast neoplasms - drug therapy (2416) 2416
animals (2319) 2319
analysis (1943) 1943
treatment outcome (1859) 1859
care and treatment (1786) 1786
pharmacology & pharmacy (1741) 1741
anthracycline (1620) 1620
doxorubicin - administration & dosage (1564) 1564
medicine & public health (1446) 1446
therapy (1439) 1439
antineoplastic agents - therapeutic use (1407) 1407
breast neoplasms - pathology (1351) 1351
drugs (1332) 1332
research (1328) 1328
cell line, tumor (1309) 1309
tumors (1269) 1269
mice (1212) 1212
health aspects (1204) 1204
anthracyclines - therapeutic use (1202) 1202
doxorubicin - therapeutic use (1171) 1171
drug delivery systems (1161) 1161
apoptosis (1154) 1154
cardiotoxicity (1104) 1104
cyclophosphamide (1082) 1082
hematology (1062) 1062
doxorubicin - pharmacology (1021) 1021
prognosis (1020) 1020
toxicity (951) 951
antineoplastic combined chemotherapy protocols - adverse effects (937) 937
metastasis (927) 927
drug therapy (912) 912
nanoparticles (907) 907
cancer therapies (892) 892
vehicles (857) 857
anthracyclines - administration & dosage (856) 856
disease-free survival (854) 854
paclitaxel (842) 842
neoplasms - drug therapy (830) 830
survival (820) 820
antibiotics, antineoplastic - therapeutic use (811) 811
retrospective studies (786) 786
anthracyclines - adverse effects (781) 781
oncology, experimental (730) 730
aged, 80 and over (725) 725
expression (725) 725
adolescent (690) 690
antineoplastic agents - adverse effects (690) 690
antibiotics, antineoplastic - administration & dosage (671) 671
doxorubicin - adverse effects (671) 671
clinical trials (651) 651
neoplasm staging (646) 646
risk factors (641) 641
antineoplastic agents - pharmacology (639) 639
cytotoxicity (624) 624
pharmacology/toxicology (619) 619
chemotherapy, adjuvant (618) 618
hematology, oncology and palliative medicine (617) 617
proteins (604) 604
young adult (602) 602
docetaxel (601) 601
dose-response relationship, drug (593) 593
survival analysis (589) 589
trastuzumab (588) 588
cancer research (584) 584
drug resistance (572) 572
antineoplastic combined chemotherapy protocols - administration & dosage (561) 561
survival rate (560) 560
antineoplastic agents - administration & dosage (550) 550
cyclophosphamide - administration & dosage (549) 549
apoptosis - drug effects (547) 547
trial (545) 545
rats (542) 542
leukemia (540) 540
patients (532) 532
breast-cancer (531) 531
cells (522) 522
gene expression (521) 521
epirubicin (519) 519
taxoids - administration & dosage (518) 518
in-vitro (517) 517
follow-up studies (514) 514
medicine (510) 510
chemistry, multidisciplinary (506) 506
antibiotics, antineoplastic - adverse effects (504) 504
medical research (504) 504
child (497) 497
drug resistance, neoplasm (497) 497
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (10658) 10658
Japanese (78) 78
French (34) 34
Chinese (33) 33
German (29) 29
Russian (21) 21
Italian (16) 16
Polish (12) 12
Spanish (10) 10
Portuguese (8) 8
Hungarian (6) 6
Danish (4) 4
Dutch (4) 4
Czech (3) 3
Finnish (2) 2
Norwegian (2) 2
Arabic (1) 1
Hebrew (1) 1
Lithuanian (1) 1
Serbian (1) 1
Slovak (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Paediatric drugs, ISSN 1174-5878, 2010, Volume 12, Issue 2, pp. 85 - 98
Hodgkin lymphoma is one of the few cancers that affect both adults and children. Cure rates for Hodgkin lymphoma remain among the best for pediatric cancers.... 
Anthracyclines, therapeutic use | Chlormethine, therapeutic use | Alkylating-agents, therapeutic use | Brentuximab-vedotin, therapeutic use | Cisplatin, therapeutic use | Bortezomib, therapeutic use | Bleomycin, therapeutic use | Children | Index Medicus
Journal Article
Biomaterials, ISSN 0142-9612, 2014, Volume 35, Issue 22, pp. 5847 - 5861
Journal Article
The lancet oncology, ISSN 1470-2045, 2014, Volume 15, Issue 9, pp. 1019 - 1026
Summary Background Present first-line therapy for diffuse large B-cell lymphoma, a subtype of non-Hodgkin lymphoma, is rituximab, cyclophosphamide,... 
Hematology, Oncology and Palliative Medicine | THERAPY | OLDER PATIENTS | ONCOLOGY | FEBRILE NEUTROPENIA | PCI-32765 | CHRONIC LYMPHOCYTIC-LEUKEMIA | CLASSIFICATION | RANDOMIZED CONTROLLED-TRIAL | TARGETING BTK | ELDERLY-PATIENTS | CHEMOTHERAPY | Doxorubicin - therapeutic use | Pyrazoles - therapeutic use | Prognosis | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Cyclophosphamide - adverse effects | Cyclophosphamide - therapeutic use | Dose-Response Relationship, Drug | Young Adult | Non-Randomized Controlled Trials as Topic | Aged, 80 and over | Adult | Female | Lymphoma, Non-Hodgkin - drug therapy | Pyrazoles - adverse effects | Severity of Illness Index | Antigens, CD20 - immunology | Lymphoma, Large B-Cell, Diffuse - drug therapy | Prednisone - adverse effects | Drug Administration Schedule | Administration, Oral | Rituximab | Survival Rate | Treatment Outcome | Lymphoma, Large B-Cell, Diffuse - mortality | Disease-Free Survival | Lymphoma, Large B-Cell, Diffuse - diagnosis | Maximum Tolerated Dose | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Pyrimidines - therapeutic use | Pyrimidines - adverse effects | Vincristine - therapeutic use | Vincristine - adverse effects | Aged | Lymphoma, Non-Hodgkin - mortality | Antigens, CD20 - drug effects | Antibodies, Monoclonal, Murine-Derived - adverse effects | Doxorubicin - adverse effects | Prednisone - therapeutic use | Antibodies, Monoclonal, Murine-Derived - therapeutic use | Lymphoma, Non-Hodgkin - diagnosis | Care and treatment | Anthracyclines | Cyclophosphamide | Prednisone | Corticosteroids | Tumors
Journal Article
Journal Article
Biomaterials, ISSN 0142-9612, 2015, Volume 63, pp. 115 - 127
Abstract To integrate biological imaging and multimodal therapies into one platform for enhanced anti-cancer efficacy, we have designed a novel core/shell... 
Advanced Basic Science | Dentistry | Photodynamic | pH/temperature-responsive | Photothermal | Up-conversion | PH/temperature-responsive | NEAR-INFRARED LIGHT | MATERIALS SCIENCE, BIOMATERIALS | PHOTODYNAMIC THERAPY | UPCONVERTING NANOPARTICLES | ENGINEERING, BIOMEDICAL | NANOPHOSPHORS | NANOCRYSTALS | MESOPOROUS SILICA NANOPARTICLES | DELIVERY | LUMINESCENCE | UP-CONVERSION NANOPARTICLES | Doxorubicin - therapeutic use | Optical Imaging | Luminescent Agents - chemistry | Temperature | Photochemotherapy - methods | Humans | Polymethacrylic Acids - therapeutic use | Delayed-Action Preparations - chemistry | Tomography, X-Ray Computed | Neoplasms - diagnosis | Nanoconjugates - therapeutic use | Neoplasms - therapy | Theranostic Nanomedicine - methods | Female | Hyperthermia, Induced - methods | Doxorubicin - administration & dosage | Nanoconjugates - ultrastructure | Polymethacrylic Acids - chemistry | Acrylamides - chemistry | Antibiotics, Antineoplastic - administration & dosage | Animals | Luminescent Agents - therapeutic use | Antibiotics, Antineoplastic - therapeutic use | Cell Line, Tumor | Delayed-Action Preparations - therapeutic use | Drug Liberation | Acrylamides - therapeutic use | Mice | Mice, Inbred BALB C | Nanoconjugates - chemistry | Hydrogen-Ion Concentration | CT imaging | Chemotherapy | Anthracyclines | Polymers | Photochemotherapy | Cancer | Rare earth metals | Surgical implants | Therapy | Platforms | Upconversion | Effectiveness | Imaging
Journal Article
Annals of oncology, ISSN 0923-7534, 2013, Volume 24, Issue 9, pp. 2278 - 2284
Journal Article
British journal of clinical pharmacology, ISSN 0306-5251, 2017, Volume 83, Issue 10, pp. 2148 - 2162
Aims Aprepitant and fosaprepitant, commonly used for the prevention of chemotherapy‐induced nausea and vomiting, alter cytochrome P450 activity. This... 
aprepitant | drug–drug interactions | fosaprepitant | METHYLENE-BLUE | CHEMOTHERAPY-INDUCED NAUSEA | SITE ADVERSE EVENTS | CYTOCHROME-P450 3A4 | IFOSFAMIDE | drug-drug interactions | CANCER-PATIENTS | CONCISE GUIDE | PHARMACOKINETICS | PHARMACOLOGY & PHARMACY | INDUCED NEUROTOXICITY | RECEPTOR ANTAGONIST APREPITANT | Cytochrome P-450 CYP3A Inhibitors - pharmacology | Nausea - chemically induced | Humans | Antineoplastic Agents - therapeutic use | Drug Interactions | Cytochrome P-450 CYP2C9 Inducers - pharmacology | Antiemetics - therapeutic use | Antineoplastic Agents - pharmacology | Vomiting - prevention & control | Morpholines - therapeutic use | Quetiapine Fumarate - pharmacology | Aprepitant | Oxycodone - therapeutic use | Oxycodone - pharmacology | Injection Site Reaction - etiology | Serotonin Uptake Inhibitors - therapeutic use | Morpholines - pharmacology | Quetiapine Fumarate - therapeutic use | Nausea - prevention & control | Vomiting - chemically induced | Ethanol - pharmacology | Serotonin and Noradrenaline Reuptake Inhibitors - pharmacology | Cytochrome P-450 CYP2C9 Inducers - therapeutic use | Serotonin and Noradrenaline Reuptake Inhibitors - therapeutic use | Cytochrome P-450 CYP3A Inhibitors - therapeutic use | Antiemetics - pharmacology | Complications and side effects | Anthracyclines | Chemotherapy | Corticosteroids | Gastrointestinal agents | Drug interactions | Nausea | Cancer | Index Medicus | Systematic Review and Meta–Analysis
Journal Article
Biomaterials, ISSN 0142-9612, 2014, Volume 35, Issue 22, pp. 5805 - 5813
Journal Article
Journal Article
Journal Article
Journal Article